Black Diamond Therapeutics (BDTX) Total Liabilities: 2018-2021
Historic Total Liabilities for Black Diamond Therapeutics (BDTX) over the last 3 years, with Sep 2021 value amounting to $55.2 million.
- Black Diamond Therapeutics' Total Liabilities rose 189.04% to $55.2 million in Q3 2021 from the same period last year, while for Sep 2021 it was $55.2 million, marking a year-over-year increase of 189.04%. This contributed to the annual value of $21.9 million for FY2020, which is 349.11% up from last year.
- Black Diamond Therapeutics' Total Liabilities amounted to $55.2 million in Q3 2021, which was up 49.69% from $36.9 million recorded in Q2 2021.
- In the past 5 years, Black Diamond Therapeutics' Total Liabilities registered a high of $55.2 million during Q3 2021, and its lowest value of $4.9 million during Q4 2019.
- Its 3-year average for Total Liabilities is $25.0 million, with a median of $21.9 million in 2020.
- As far as peak fluctuations go, Black Diamond Therapeutics' Total Liabilities slumped by 79.84% in 2020, and later soared by 482.80% in 2021.
- Black Diamond Therapeutics' Total Liabilities (Quarterly) stood at $6.6 million in 2018, then declined by 26.05% to $4.9 million in 2019, then soared by 349.11% to $21.9 million in 2020, then spiked by 189.04% to $55.2 million in 2021.
- Its last three reported values are $55.2 million in Q3 2021, $36.9 million for Q2 2021, and $32.5 million during Q1 2021.